Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-049120)

Filing Details

Accession Number:: 0001209191-21-049120
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-02 18:49:11
Reporting Period:: 2021-07-29

Accepted Time:: 2021-08-02 18:49:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662579	C4 Therapeutics Inc.	CCCC	Biological Products, (No Disgnostic Substances) (2836)	475617627

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1768223	Jolie Siegel	C/O C4 Therapeutics, Inc. 490 Arsenal Way #200 Watertown MA 02472	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-29	12,500	$4.98	12,500	No	4	M	Direct
Common Stock	Disposition	2021-07-29	12,500	$45.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-07-29	12,500	$0.00	12,500	$4.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
283,821		2030-07-02	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter.